Newtopia Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Jeff Ruby

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	5.1yrs
CEO ownership	5.0%
Management average tenure	2yrs
Board average tenure	4yrs

Recent management updates

Recent updates

Companies Like Newtopia (CVE:NEWU) Are In A Position To Invest In Growth

Apr 08

CEO Compensation Analysis

How has Jeff Ruby's remuneration changed compared to Newtopia's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2023	n/a	n/a	-CA$5m
Jun 30 2023	n/a	n/a	-CA$6m
Mar 31 2023	n/a	n/a	-CA$7m
Dec 31 2022	n/a	n/a	-CA$8m
Sep 30 2022	n/a	n/a	-CA$8m
Jun 30 2022	n/a	n/a	-CA$7m
Mar 31 2022	n/a	n/a	-CA$7m
Dec 31 2021	CA$399k	CA$300k	-CA$8m
Sep 30 2021	n/a	n/a	-CA$9m
Jun 30 2021	n/a	n/a	-CA$9m
Mar 31 2021	n/a	n/a	-CA$9m
Dec 31 2020	CA$690k	CA$300k	-CA$8m
Sep 30 2020	n/a	n/a	-CA$9m
Jun 30 2020	n/a	n/a	-CA$9m
Mar 31 2020	n/a	n/a	-CA$10m
Dec 31 2019	CA$300k	CA$300k	-CA$10m

Compensation vs Market: Insufficient data to establish whether Jeff's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: Jeff's compensation has been consistent with company performance over the past year.

CEO

Jeff Ruby (48 yo)

5.1yrs

Tenure

CA$398,747

Compensation

Mr. Jeffrey Ruby, also known as Jeff, J.D., MBA serves as Chairman at Newtopia Inc. since May 27, 2020. Mr. Ruby is the Founder and Chief Executive Officer of Newtopia Inc. He has been Director at Newtopia...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Jeffrey Ruby	Founder	no data	CA$398.75k	4.97% CA$ 387.4k
Lara Dodo	Chief Growth Officer & COO	3.5yrs	CA$400.00k	0.12% CA$ 9.0k
Peter Seider	Chief Information	no data	CA$210.00k	no data
Collin Swenson	Chief Financial Officer	2yrs	no data	no data
Karyn Hood	Head of Behavioral & Mental Health	no data	no data	no data
Rikki Bennie	Senior Vice President	no data	no data	0.48% CA$ 37.2k
Mark Jackson	Senior Vice President of Commercial	no data	no data	no data
Louis Perusse	Head of Genetics	2.3yrs	no data	no data
Leonard Fensterheim	Senior Vice President of Outcomes	1.8yrs	no data	no data
Gilles Lapointe	Head of Genetics	1.8yrs	no data	no data

2.0yrs

Average Tenure

55yo

Average Age

Experienced Management: NEWU's management team is considered experienced (2 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Jeffrey Ruby	Founder	5.1yrs	CA$398.75k	4.97% CA$ 387.4k
Karen Basian	Independent Director	4.2yrs	CA$75.16k	0.22% CA$ 17.0k
Michael Palmer	Lead Independent Director	4.2yrs	CA$85.22k	0.20% CA$ 15.8k
Roger Poirier	Independent Director	2.8yrs	CA$27.50k	8.57% CA$ 668.5k
Nancy Cocozza	Member of Advisory Board	no data	no data	no data
Gregory Steinberg	Member of Advisory Board	4yrs	no data	no data
William Van Wyck	Member of Advisory Board	less than a year	CA$199.78k	no data
Gil Bashe	Member of Advisory Board	2.3yrs	no data	no data
Mike Payne	Member of Advisory Board	4yrs	no data	no data
Hassan Azar	Member of Advisory Board	4yrs	no data	no data
Carleen Hawn	Independent Director	4.2yrs	CA$55.16k	no data
Claire Spettell	Member of Advisory Board	3.6yrs	no data	no data

4.0yrs

Average Tenure

57yo

Average Age

Experienced Board: NEWU's board of directors are considered experienced (4 years average tenure).

Newtopia Management

Management criteria checks 3/4

Key information

Recent management updates

High number of new and inexperienced directors

Newtopia Inc., Annual General Meeting, Sep 14, 2022

Newtopia Inc. Announces Chief Financial Officer Changes

High number of new and inexperienced directors

Director recently bought CA$105k worth of stock

Director recently bought CA$78k worth of stock

Recent updates

New major risk - Market cap size

Newtopia Inc. announced that it has received CAD 0.7465 million in funding

New minor risk - Share price stability

Newtopia Launches "Glp-1 Sustain" Program to Affordably Preserve and Extend Valuable Health Benefits of Novel Weight Loss Drugs

New major risk - Market cap size

Third quarter 2023 earnings released: CA$0.005 loss per share (vs CA$0.019 loss in 3Q 2022)

Newtopia Inc. to Report Q3, 2023 Results on Nov 16, 2023

Newtopia Inc. announced that it has received CAD 0.805 million in funding

Second quarter 2023 earnings released: CA$0.008 loss per share (vs CA$0.02 loss in 2Q 2022)

Newtopia Inc. to Report Q2, 2023 Results on Aug 09, 2023

Newtopia Inc. announced that it expects to receive CAD 0.5 million in funding

Newtopia Inc. announced that it expects to receive CAD 0.5 million in funding

Newtopia Inc. announced that it has received CAD 0.0075 million in funding

First quarter 2023 earnings released: CA$0.01 loss per share (vs CA$0.016 loss in 1Q 2022)

Newtopia Inc. to Report Q1, 2023 Results on May 30, 2023

Full year 2022 earnings released: CA$0.065 loss per share (vs CA$0.076 loss in FY 2021)

Newtopia Inc. announced that it has received CAD 1.35 million in funding

Newtopia Inc. announced that it expects to receive CAD 1.35 million in funding

High number of new and inexperienced directors

Newtopia Inc. and Eastern Health Improve Outcomes for Individuals Living with Type 2 Diabetes

Third quarter 2022 earnings released: CA$0.019 loss per share (vs CA$0.011 loss in 3Q 2021)

Newtopia Inc. Provides Revenue Guidance for the Year 2022

Newtopia Inc. to Report Q3, 2022 Results on Nov 08, 2022

Second quarter 2022 earnings released: CA$0.02 loss per share (vs CA$0.024 loss in 2Q 2021)

Newtopia Inc. Provides Revenue Guidance for the Year 2022

Newtopia Inc. to Report Q2, 2022 Results on Aug 10, 2022

Newtopia Inc., Annual General Meeting, Sep 14, 2022

Newtopia Launches New Engagement Platform and Brand Refresh While Combating Costly Chronic Conditions

First quarter 2022 earnings released: CA$0.016 loss per share (vs CA$0.023 loss in 1Q 2021)

Newtopia Inc. Provides Revenue Guidance for the Second Half and Full Year of 2022

Newtopia Inc. to Report Q1, 2022 Results on May 18, 2022

Price target decreased to CA$0.55

Newtopia Inc. Announces Chief Financial Officer Changes

Price target decreased to CA$0.69

High number of new and inexperienced directors

Full year 2021 earnings released: CA$0.076 loss per share (vs CA$0.12 loss in FY 2020)

Newtopia Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2022

Newtopia Inc. to Report Q4, 2021 Results on Apr 05, 2022

Newtopia Inc. to Report Q4, 2021 Results on Apr 05, 2022

Director recently bought CA$105k worth of stock

Third quarter 2021 earnings released: CA$0.011 loss per share (vs CA$0.019 loss in 3Q 2020)

Price target decreased to CA$0.82

Director recently bought CA$78k worth of stock

Independent Director recently bought CA$100k worth of stock

Second quarter 2021 earnings released: CA$0.024 loss per share (vs CA$0.025 loss in 2Q 2020)

Chief Financial Officer Anthony Lam has left the company

First quarter 2021 earnings released: CA$0.023 loss per share (vs CA$0.097 loss in 1Q 2020)

Newtopia Inc. Provides Revenue Guidance for the Year 2021

Companies Like Newtopia (CVE:NEWU) Are In A Position To Invest In Growth

Full year 2020 earnings released: CA$0.12 loss per share (vs CA$0.65 loss in FY 2019)

New 90-day low: CA$0.56

Newtopia Inc Launches Habit Change Provider Category

New 90-day low: CA$0.57

New 90-day low: CA$0.71

New 90-day low: CA$0.72

Revenue misses expectations

Third quarter 2020 earnings released: CA$0.019 loss per share

Newtopia Inc. Strengthens Leadership Team with Appointment of Executive Leaders

Newtopia Inc. announced that it has received CAD 7.505 million in funding

Newtopia Inc. Appoints Claire Spettell as an Advisory Board Member

New 90-day high: CA$1.05

Earnings released

New 90-day high - CA$0.62

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure